ES2051687T3 - Procedimiento de preparar un gel basico coloidal que contiene pirimicina. - Google Patents

Procedimiento de preparar un gel basico coloidal que contiene pirimicina.

Info

Publication number
ES2051687T3
ES2051687T3 ES86116439T ES86116439T ES2051687T3 ES 2051687 T3 ES2051687 T3 ES 2051687T3 ES 86116439 T ES86116439 T ES 86116439T ES 86116439 T ES86116439 T ES 86116439T ES 2051687 T3 ES2051687 T3 ES 2051687T3
Authority
ES
Spain
Prior art keywords
primicine
gel containing
substances
pyrimycin
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86116439T
Other languages
English (en)
Inventor
Peter Szentmiklosi
Tamas Szuets
Jozsef Nemes
Jozsef Lengyel
Jenoe Marton
Nee Vajas Erzsebet Babos
Nee Kovats Enikoe Schreiner
Peter Sarkoezi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU864689A external-priority patent/HU197989B/hu
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of ES2051687T3 publication Critical patent/ES2051687T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL INVENTO CONSISTE EN UN GEL COLOIDAL QUE CONTIENE PRIMICINA, HASTA UN 30%, PREFERENTEMENTE DE UN 5 A UN 30% Y N - METIL - PIRROLIDON - 2 (NMP), DE UN 95 A UN 70%. ADEMAS CONTIENE UNO O MAS PRINCIPIOS ACTIVOS ANTIBACTERIANOS ADICIONALES, PREFERENTEMENTE ANTIBIOTICOS, QUE A TRAVES DE LA DISOLUCION DE PRIMICINA EN NMP POR AUMENTO DE TEMPERATURA Y ENFRIAMIENTO A TEMPERATURA AMBIENTE PUEDEN ESTAR CONTENIDOS EN EL. EL INVENTO DESCRIBE ADEMAS, PREPARADOS ANTIBACTERIANOS (PRINCIPALMENTE PARA EL TRATAMIENTO AKNE VULGARIS), QUE CONTIENE DE UN 0,1 A UN L00% DE GEL QUE CONTIENE PRIMICINA COMO PRINCIPIO ACTIVO Y OTROS PRINCIPIOS ACTIVOS FARMACEUTICOS, Y DE UN 99,9 A UN 0% DE DIVERSOS RELLENOS, SUSTANCIAS DILUIDAS O MATERIAS AUXILIARES. EL PREPARADO COMBINADO CONTIENE COMO PRINCIPIO ACTIVO DE 1 A 60% DEL GEL DE PRIMICINA Y DEL 0,1 A 40% DE UNO O MAS PRINCIPIOS FARMACEUTICOS, PREFERENTEMENTE ANTIBIOTICOS, SUSTANCIAS QUIMIOTERAPEUTICAS, ESTEROIDES O NO ESTEROIDES, SUSTANCIAS QUE PROMOCIONAN LA UNION EPITELIAL, SUSTANCIAS ANESTESICAS LOCALES Y/O VITAMINAS.
ES86116439T 1985-11-27 1986-11-26 Procedimiento de preparar un gel basico coloidal que contiene pirimicina. Expired - Lifetime ES2051687T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU854526A HU194493B (en) 1985-11-27 1985-11-27 Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
HU864689A HU197989B (en) 1986-11-14 1986-11-14 Method for producing novel preparation of primicine gel base

Publications (1)

Publication Number Publication Date
ES2051687T3 true ES2051687T3 (es) 1994-07-01

Family

ID=26317774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86116439T Expired - Lifetime ES2051687T3 (es) 1985-11-27 1986-11-26 Procedimiento de preparar un gel basico coloidal que contiene pirimicina.

Country Status (13)

Country Link
US (1) US5064815A (es)
EP (1) EP0224868B1 (es)
AT (1) ATE66610T1 (es)
CZ (1) CZ868686A3 (es)
DE (1) DE3681127D1 (es)
DK (1) DK568486A (es)
ES (1) ES2051687T3 (es)
FI (1) FI87527C (es)
GR (1) GR3002624T3 (es)
HU (1) HU194493B (es)
NO (1) NO864718D0 (es)
PL (1) PL151121B1 (es)
YU (2) YU45383B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203476B (en) * 1988-06-16 1991-08-28 Chinoin Gyogyszer Es Vegyeszet Process for producing stabile, aquous suspoemulsion containing primicin and suspoemulsionic pharmaceutical composition containing them as active component
US5217707A (en) * 1988-06-16 1993-06-08 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Pharmaceutical composition and process for the preparation thereof
HUT52959A (en) * 1988-07-19 1990-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of syergethic compositions
US5244880A (en) * 1988-11-02 1993-09-14 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions
HU201876B (en) * 1988-11-02 1991-01-28 Chinoin Gyogyszer Es Vegyeszet Process for producing stabile aquous solutions of primicin and pharmaceutical and desinficient compositions containing them
HU207222B (en) * 1990-02-15 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing eyedrops containing primycin
GB2290709A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of nystatin
GB2290708A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of polyene macrolides
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
GB0307869D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132781A (en) * 1974-12-19 1979-01-02 Nelson Research & Development Company Method for treatment of acne
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4268498A (en) * 1979-07-16 1981-05-19 Revlon, Inc. Clear cosmetic sticks
DE3104282A1 (de) * 1981-02-07 1982-10-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára RT, 1045 Budapest Synergistisch antimikrobiell wirksames therapeutisches praeparat und ein verfahren zu dessen herstellung
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one

Also Published As

Publication number Publication date
FI864795A0 (fi) 1986-11-25
EP0224868B1 (de) 1991-08-28
DK568486D0 (da) 1986-11-26
YU45836B (sh) 1992-07-20
YU228687A (en) 1988-08-31
US5064815A (en) 1991-11-12
YU202786A (en) 1988-06-30
DE3681127D1 (de) 1991-10-02
HU194493B (en) 1988-02-29
PL262631A1 (en) 1988-07-21
FI87527C (fi) 1993-01-25
NO864718D0 (no) 1986-11-25
ATE66610T1 (de) 1991-09-15
EP0224868A2 (de) 1987-06-10
GR3002624T3 (en) 1993-01-25
YU45383B (en) 1992-05-28
PL151121B1 (en) 1990-08-31
HUT42320A (en) 1987-07-28
CZ868686A3 (en) 1993-12-15
FI87527B (fi) 1992-10-15
EP0224868A3 (en) 1987-08-26
DK568486A (da) 1987-05-28
FI864795A7 (fi) 1987-05-28

Similar Documents

Publication Publication Date Title
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
MY101791A (en) New benzimidazole derivatives
ZA885192B (en) Pharmaceutical preparations
PT74703A (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ATE157542T1 (de) Verwendung von einer disaccharidpolysulfat- aluminium verbindung zur herstellung eines medikaments zur behandlung von hämorrhoiden und zur wundheilung
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ATE30575T1 (de) Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten.
SE8300736D0 (sv) Novel pharmacologically active compounds
ES2038122T3 (es) Un procedimiento para la preparacion de una composicion veterinaria2.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
HUT47124A (en) Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients
GR3002624T3 (en) Primycine-containing colloidal basic gel, process for its preparation and pharmaceutical or pharmaco-cosmetic compositions containing the basic gel
SE8501532D0 (sv) Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning
AU4040195A (en) Topical composition containing penciclovir
ES2053679T3 (es) Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
IL94621A0 (en) Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 224868

Country of ref document: ES